[1]
A. Arenas, D. Ruedi, G. Walsen, and P. Ibañez, “Empirical anti-TNF dose intensification in inflammatory bowel disease: real-world outcomes from a resource-limited setting”, JGLD, vol. 35, no. 3, pp. 499–500, Sep. 2026.